Pfizer’s PCV20 offers single-shot protection against 20 pneumococcal serotypes, safeguarding adults from serious respiratory ...

A next-generation pneumococcal conjugate vaccine, PCV20, a single-dose protection is now available in India marking a new ...

For decades, doctors have worked to protect people from Streptococcus pneumoniae, a bacterium responsible for pneumonia, ...

Pfizer has launched its 20-valent pneumococcal conjugate vaccine (PCV20) in India, offering single-dose protection against 20 ...

In a recent multicenter prospective study conducted at three hospitals in Tennessee and Georgia, including Vanderbilt ...

Study: Longitudinal dynamics of Streptococcus pneumoniae carriage and SARS-CoV-2 infection in households with children. Image Credit: Lotus_studio / Shutterstock.com ...

Thus, our finding of PspA's role in adherence substantially advances our knowledge on the interactions of S. pneumoniae with its host." Reference: Park S-S, Gonzalez-Juarbe N, Riegler AN, et al.

Streptococcus pneumoniae binds to host GAPDH on dying lung epithelial cells worsening secondary infection following influenza. Cell Reports, 2021; 35 (11): 109267 DOI: 10.1016/j.celrep.2021.109267 ...

Scientists from the UK and US have recently investigated immunological consequences of secondary Streptococcus pneumoniae (S. pneumoniae) infection in coronavirus disease 2019 (COVID-19) patients.

The emergence of Streptococcus pneumoniae that is resistant to the β-lactam and macrolide antimicrobial drugs has aroused concern about the use of these agents for the empirical treatment of ...

Streptococcus pneumoniae is the leading bacterial cause of pneumonia, sepsis, and meningitis in children, which together comprise more than 25% of the 10 million deaths estimated to have occurred ...